Misonix acquires Solys Medical — 4 things to know

Written by Alan Condon | September 30, 2019 | Print  |

Misonix completed the acquisition of Solys Medical.

Four things to know:

1. The acquisition was an all-stock transaction of roughly $109 million in value on the date prior to closing.

2. In the deal, Misonix acquired TheraSkin, Solys Medical's cellular and tissue-based wound treatment.

3. The acquisition consisted of the issuance of around 5.7 million new shares to former Solys unitholders.

4. Misonix assumed Solsys' outstanding secured debt of roughly $24 million.

More articles on devices:
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
Dr. Timothy Kremchek to operate on Reds rookie Nick Senzel — 4 insights
Icotec to introduce new pedicle screw system — 4 insights 

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers